CNSX:LOVECannara Biotech Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Cannara Biotech Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Share Today's Range N/A50-Day Range$0.10MA: $0.10▼$0.1152-Week Range N/AVolume1.13 million shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsHeadlines Cannara Biotech Inc. is a vertically integrated cannabis company building the largest indoor cannabis cultivation facility in Quebec, a modern and secure 625,000 square foot facility. Leveraging Quebec's low electricity costs, Cannara will produce high-grade indoor cannabis, specializing in derivative products and brands.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Cannara Biotech. Previous Next 3.4 Community Rank Outperform VotesCannara Biotech has received 47 “outperform” votes. (Add your “outperform” vote.)Underperform VotesCannara Biotech has received 23 “underperform” votes. (Add your “underperform” vote.)Community SentimentCannara Biotech has received 67.14% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Cannara Biotech and other stocks. Vote “Outperform” if you believe LOVE will outperform the S&P 500 over the long term. Vote “Underperform” if you believe LOVE will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldCannara Biotech does not currently pay a dividend.Dividend GrowthCannara Biotech does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cannara Biotech insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 3.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.68 out of 5 stars Industry, Sector and Symbol Stock Exchange CNSX Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolCNSX:LOVE Previous Symbol CUSIPN/A CIKN/A Webcannara.ca PhoneN/ADebt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable TSXV:LOVE Rates by TradingView Receive LOVE News and Ratings via Email Sign-up to receive the latest news and ratings for LOVE and its competitors with MarketBeat's FREE daily newsletter. Cannara Biotech (CNSX:LOVE) Frequently Asked Questions Has Cannara Biotech been receiving favorable news coverage? News headlines about LOVE stock have been trending negative on Friday, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Cannara Biotech earned a media sentiment score of -2.4 on InfoTrie's scale. They also gave news articles about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the next few days. View the latest news about Cannara Biotech. Who are some of Cannara Biotech's key competitors? Some companies that are related to Cannara Biotech include 1933 Industries (TGIF), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Biome Grow (BIO), Blueberries Medical (BBM), Canbiola (CANB), Cansortium (CNTMF), Charlotte's Web (CWBHF), Choom (CHOOF), Cipher Pharmaceuticals (CPHRF), CLS Holdings USA (CLSH) and Cosmos (COSM). View all competitors. What other stocks do shareholders of Cannara Biotech own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cannara Biotech investors own include Aurora Cannabis (ACB), Aurora Cannabis (ACB), FSD Pharma (HUGE), Harvest One Cannabis (HVT), Green Organic Dutchman (TGOD), Aphria (APHA), OrganiGram (OGI), Canopy Growth (WEED), AcelRx Pharmaceuticals (ACRX) and Cross Timbers Royalty Trust (CRT). What is Cannara Biotech's stock symbol? Cannara Biotech trades on the CNSX under the ticker symbol "LOVE." How do I buy shares of Cannara Biotech? Shares of LOVE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Cannara Biotech's official website? The official website for Cannara Biotech is cannara.ca. This page was last updated on 7/10/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
